Suppr超能文献

茶多酚的最新进展。

Recent advances on tea polyphenols.

作者信息

Kanwar Jyoti, Taskeen Mujtaba, Mohammad Imthiyaz, Huo Congde, Chan Tak Hang, Dou Qing Ping

机构信息

The Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, and Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

Front Biosci (Elite Ed). 2012 Jan 1;4(1):111-31. doi: 10.2741/363.

Abstract

Over the past decade many scientific and medical studies have focused on green tea for its long-purported health benefits. There is convincing evidence that tea is a cup of life. It has multiple preventive and therapeutic effects. This review thus focuses on the recent advances of tea polyphenols and their applications in the prevention and treatment of human cancers. Of the various polyphenols in tea, (-)-Epigallocatechin-3-gallate (EGCG) is the most abundant, and active compound studied in tea research. EGCG inhibits several molecular targets to inhibit cancer initiation and modulates several essential survival pathways to block cancer progression. Herein, we describe the various mechanisms of action of EGCG and also discuss previous and current ongoing clinical trials of EGCG and green tea polyphenols in different cancer types.

摘要

在过去十年中,许多科学和医学研究都聚焦于绿茶,因其长期以来被认为具有有益健康的功效。有令人信服的证据表明,茶是一杯生命之饮。它具有多种预防和治疗作用。因此,本综述重点关注茶多酚的最新进展及其在人类癌症预防和治疗中的应用。在茶的各种多酚中,(-)-表没食子儿茶素-3-没食子酸酯(EGCG)是茶研究中含量最丰富且活性最强的化合物。EGCG抑制多种分子靶点以抑制癌症起始,并调节多种关键的生存途径以阻断癌症进展。在此,我们描述了EGCG的各种作用机制,并讨论了EGCG和绿茶多酚在不同癌症类型中的既往及当前正在进行的临床试验。

相似文献

1
Recent advances on tea polyphenols.茶多酚的最新进展。
Front Biosci (Elite Ed). 2012 Jan 1;4(1):111-31. doi: 10.2741/363.
5
Molecular mechanisms of green tea polyphenols.绿茶多酚的分子机制。
Nutr Cancer. 2009;61(6):827-35. doi: 10.1080/01635580903285049.
9
Perspectives on the recent developments with green tea polyphenols in drug discovery.绿茶多酚在药物发现方面的最新进展的观点。
Expert Opin Drug Discov. 2018 Jul;13(7):643-660. doi: 10.1080/17460441.2018.1465923. Epub 2018 Apr 24.

引用本文的文献

9
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma.非小细胞肺癌调控信号通路的治疗靶向
ACS Omega. 2023 Jul 17;8(30):26685-26698. doi: 10.1021/acsomega.3c02424. eCollection 2023 Aug 1.

本文引用的文献

6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验